BeOne Medicines (ONC) EPS (Weighted Average and Diluted) (2016 - 2026)
BeOne Medicines (ONC) reported EPS (Weighted Average and Diluted) of $0.15 for Q1 2026, up 275.0% on a QoQ basis from $0.04 in Q4 2025.
BeOne Medicines (ONC) has 10 years of EPS (Weighted Average and Diluted) data on file, last reported at $0.15 in Q1 2026.
- Quarterly EPS (Weighted Average and Diluted) changed N/A year-over-year to $0.15 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $0.33 (up 213.79% YoY) and the FY2025 annual result came in at $0.19, up 140.43% from the prior year.
- EPS (Weighted Average and Diluted) climbed to $0.15 in Q1 2026 per ONC's latest filing, from $0.04 in the prior quarter.
- Across five years, EPS (Weighted Average and Diluted) topped out at $0.15 in Q3 2023 and bottomed at -$0.42 in Q2 2022.
- The 5-year median for EPS (Weighted Average and Diluted) is -$0.15 (2024), against an average of -$0.14.
- The widest annual swing landed in 2022, when EPS (Weighted Average and Diluted) tumbled 760.0%; it then soared 188.89% in 2025.
- Tracing ONC's EPS (Weighted Average and Diluted) over 5 years: stood at -$0.33 in 2022, then rose by 18.18% to -$0.27 in 2023, then soared by 59.26% to -$0.11 in 2024, then jumped by 136.36% to $0.04 in 2025, then jumped by 275.0% to $0.15 in 2026.
- Per Business Quant, the three latest ONC EPS (Weighted Average and Diluted) figures stand at $0.15 (Q1 2026), $0.04 (Q4 2025), and $0.08 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -4.43 |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 3,086.42 |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 0.00 |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 4.02 |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 6.75 |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 1.51 |
| 10 | BeOne Medicines | - | - | 1.35 Bn | 0.15 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.15 |
| Dec 31, 2025 | 0.04 |
| Sep 30, 2025 | 0.08 |
| Jun 30, 2025 | 0.06 |
| Dec 31, 2024 | -0.11 |
| Sep 30, 2024 | -0.09 |
| Jun 30, 2024 | -0.09 |
| Mar 31, 2024 | -0.19 |
| Dec 31, 2023 | -0.27 |
| Sep 30, 2023 | 0.15 |
| Jun 30, 2023 | -0.28 |
| Mar 31, 2023 | -0.26 |
| Dec 31, 2022 | -0.33 |
| Sep 30, 2022 | -0.41 |
| Jun 30, 2022 | -0.42 |
| Mar 31, 2022 | -0.33 |
| Dec 31, 2021 | -0.49 |
| Sep 30, 2021 | -0.36 |
| Jun 30, 2021 | -0.40 |
| Mar 31, 2021 | 0.05 |
| Mar 31, 2020 | -0.36 |
| Sep 30, 2018 | -0.19 |
| Sep 30, 2017 | 0.20 |
| Sep 30, 2016 | -0.08 |